LIXISENATIDE (Lyxumia®)
Clinical Indication
Type 2 diabetes
Comments
Product discontinued 2023.
Non-Formulary
Date of classification
June 2015
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.